A combination product of aripiprazole (antipsychotic) and divalproex sodium (mood
stabilizer) was recently developed to establish their tolerability and safety in fixed dose …

A vast majority of psychiatric patients are effectively treated with combination of drugs to
improve efficacy and adherence, but due to limited research and development in fixed dose …

Methods The study population included 167 healthy volunteers receiving 10 mg aripiprazole
in 6 single dose clinical trials (3 Abilify® tablets and 3 Abilify® ODT) under fasting …

Abstract Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU 960) is a novel long-acting
injectable (LAI) formulation of aripiprazole monohydrate for administration once every 2 …

To assess the bioequivalence of 2 formulations of aripiprazole orally disintegrating tablets
and to monitor their safety and tolerability in Chinese subjects, a single‐site, open‐label …

Purpose The main objective of this study was to compare the pharmacokinetic properties
and relative bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating …

Objective. There is very limited documentation available on the effects of valproate co-
medication on the pharmacokinetics of aripiprazole in a naturalistic setting. The aim of the …

Background Aripiprazole lauroxil (AL) is an FDA-approved treatment for schizophrenia. AL is
a non-ester prodrug of aripiprazole that results in extended systemic release of aripiprazole …

Background Bipolar disorder (manic depression) is a serious, long-term mental illness that
affects about 1% of adults at some time during their life. It usually develops in late …

A simple and sensitive column‐switching HPLC‐UV method was developed for the
simultaneous determination of aripiprazole, a novel atypical antipsychotic drug, and its …